Glycosaminoglycan (GAG) was extracted from the porcine thyroid gland with a buffer comprising 5.3 M guanidine-HCl and proteolytic enzyme inhibitors and was fractionated by subsequent isodensity CsCl centrifugation.
It has long been known that the state of the thyroid influences the mucopolysaccharide (glycosaminoglycan, abbreviated to GAG) metabolism. For example, Schiller et al. reported an accumulation of GAG in connective tissue of myxedema (1962) . Winand et al. reported an increase in the urinary excretion of GAG in Graves' exophthalmos patients (1968) . The presence of GAG in the thyroid tissue itself was recently reported by Van Dessel in a form of abstract (1978) but its functional role still remains unknown.
Those GASs are known to be synthesized by their parent cells as components of proteoglycans (Roden, 1980) . Accordingly, in the present study, we sought to examine the presence of proteoglycan in porcine thyroid tissue. Protein was measured by the method of Lowry et al. (1951) with bovine serum albumin (BSA) as a standard.
The hexuronic acid concentration was determined by the carbazol reaction (Dische, 1947) . Sialic acid was measured by the periodate-resorcinol method of Jourdian et al. (1971) . Triiodothyronine (T3) was measured with a radioimmunoassay kit supplied by Eiken Immunochemical Laboratories (Tokyo).
Results
The D1 fraction obtained by CsCl density gradient centrifugation contained approximately 60% of the uronic acid positive materials in the thyroid gland. The amount of material in the D1 fraction was about 0.2 mg per g wet weight thyroid. Table 1 summarizes the result of analysis of the Fig. 1 and 2 . The PI, PIT and PIII contained approximately 14, 71 and 15% of the uronic acid, respectively.
Only a little protein or sialic acid was eluted in the PIII. The PIII also contained triiodothyronine measured by radioimmunoassay (Fig. 1B) . After papain or alkaline borohydride treatment, the PI desappeared ( Fig.  2B and C) . Papain digests proteins extensively and the alkaline borohydride treat ment releases GAGs from protein by the elimination reaction. The disappearance of the PI following these treatments suggests that this peak contains GAG as a form of proteoglycan. On the other hand, the elution position of the PIT was not altered by either of these treatments, indicating that GAGs in the PII are present mainly as single GAG chains with very small amounts of covalently linked peptide, if any. The molecular weight of GAGs in the PII was estimated as approximately 16,000 based on the published data on the calibration of Sepharose 6B by chondroitin sulfate chains of known molecular weight (Wasteson, 1971) .
Chondroitinase ABC treatment of the D1 sample released about 9% of the total uronic acid as low molecular weight material eluted close to the column total volume (Fig. 2D) indicating the presence of chondroitin sulfate or dermatan sulfate. The PI was not degraded by chondroitinase ABC treatment.
Nitrous acid treatment degraded the majority of the uronic acid containing material in both PI and PIT (Fig. 2E) . Degraded fragments eluted at Endocrinol.
Japon. October 1983 Kay = 0.80. A big peak at the column total volume (Fig. 2E) was due to the nonspecific color reaction caused by nitrous acid and ammonium sulfamate used for chemical reaction.
The result indicates that majority of the uronic acid containing material in the PI and PII is heparin or heparan sulfate.
Discussion
The present study confirmed the presence of GAG in the thyroid tissue as reported by Van Dessel et al. in an abstract form (1978) . The amount of GAG in the thyroid tissue was similar to that reported for other parenchymatous tissues such as liver, kidney and spleen (Slavkin et al., 1975) and far less than that in various cartilagenous tissues (Hascall et al., 1977) . More than 90% of the GAG in the thyroid tissue was heparin or heparan sulfate (sensitive to nitrous acid) and the rest was chondroitin sulfate or dermatan sulfate (sensitive to chondroitinase ABC). This report demonstrated, for the first time, that a part of the heparin or heparan sulfate (approximately 14%) is present as proteoglycans (PI in Sepharose CL-6B analysis) in the thyroid gland. The elution position of the PI on Sepharose CL-6B was very similar to that reported for the heparan sulfate proteoglycans isolated from rat liver cell membrane (Oldberg et al., 1979) , suggesting a similar molecular weight of 70,000-80,000.
The presence of heparan sulfate, extracellular matrix and basement membrane etc. (Branford White and Hardy, 1977 , Kanwar, et al. 1981 , Kraemer, 1971 , Mutoh, et al., 1978 , Norling, et al., 1981 and Oldberg, et al., 1979 . The location of heparin or heparan sulfate proteoglycans in the thyroid tissue remains to be studied.
Despite the use of strong denaturing conditions of 5.3 M guanidine HCl and protease inhibitors throughout the extraction and purification procedures, most of the GAG was present as a single chain species (PII), suggesting proteolytic degradation of proteoglycans.
The nature of such proteolysis, whether this represents physiological processes or experimental artifacts, remains to be studied further.
The PIII contained most of the protein and sialic acid in the Dl fraction.
It is therefore possible that uronic acid reaction in this peak can be due to non-specific color reaction to these molecules and may not indicate the presence of GAG. The presence of triiodothyronine immunoreactivity in this peak suggests that these molecules are derived from thyroglobulin.
The presence of such polypeptides which contain thyroxine has been reported by other investigators (Haeberli 1979 , Chernoff et al., 1981 , Dunn et al., 1981 . The high density of these molecules probably is the result of high iodine and carbohydrate content of the peptides. The physiological significance of this fraction remains to be elucidated.
